Home/All Molecules/Megestrol Acetate

Megestrol Acetate Range

Comprehensive Megestrol Acetate portfolio for Franchise & Manufacturing.

Category
megestrol-acetate
Total Formulations
2
Available Forms
Tablets

Expand Your Business with Our Multiple Divisions


Browse Megestrol Acetate portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Megestrol Acetate batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Megestrol Acetate PCD Pharma Franchise Company

Megestrol Acetate PCD Pharma Franchise Company

Cafoli Lifecare is a reliable Megestrol Acetate PCD pharma franchise company in India, offering 2 Megestrol Acetate formulations manufactured at WHO-GMP certified facilities. The range is supplied in oral tablet form, positioned for oncology support and palliative-care prescribing.

What is Megestrol Acetate?

Megestrol Acetate is a synthetic progestin derived from progesterone. Alongside its hormonal antineoplastic activity, it has a well-documented appetite-stimulant effect and is used to manage anorexia, cachexia and unexplained significant weight loss in patients with cancer or AIDS. It is also used in the palliative treatment of advanced breast and endometrial carcinoma. Compound details are available on PubChem.

Therapeutic Applications

Megestrol Acetate is used for the treatment of anorexia, cachexia and unexplained weight loss in advanced cancer and AIDS, and in the palliative management of advanced hormone-responsive breast and endometrial carcinoma. It is prescribed by medical oncologists, palliative-care physicians, gynaecological oncologists and physicians managing HIV-associated wasting.

Why Megestrol Acetate is a High-Potential Molecule for Distributors

This is a low-volume, high-value specialty line rather than a mass-market product, and that is precisely its appeal. Oncology and palliative-care molecules face far less price undercutting than general generics, sustain healthier per-unit margins, and are prescribed with strong brand continuity because oncologists rarely switch a stabilised patient. Demand concentrates around cancer hospitals, oncology day-care centres and palliative units — accounts that are hard for competitors to break into once supply reliability is proven. For a distributor building an oncology or institutional vertical, Megestrol Acetate is an efficient entry point requiring only two SKUs of inventory.

Why Choose Cafoli Lifecare

Cafoli Lifecare provides exclusive monopoly rights in your territory, WHO-GMP certified and DCGI-approved manufacturing, consistent stock availability, competitive margins, and complete promotional inputs including visual aids, samples, MR bags, catch covers and reminder cards. We work with a network of 1000+ franchise partners across India.

References

  1. PubChem — Megestrol Acetate Compound Summary, National Library of Medicine
  2. PubMed — Clinical literature on Megestrol Acetate in cachexia

Aceclofenac in Modern Clinical Practice

Our formulations of Megestrol Acetate find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Megestrol Acetate in PCD Franchise

Start Your Megestrol Acetate Franchise with Cafoli Lifecare

Enter the oncology and palliative-care segment with a high-value specialty line and monopoly rights in your district. Call +91 95184 47302 or email info@cafoli.in for the latest Megestrol Acetate price list, packing details and territory availability.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 2 Megestrol Acetate formulations, supplied as oral tablets used for cancer-related anorexia and cachexia and in palliative hormone therapy. Call 9518447302 for the current list with packing and pricing details.

Yes. Monopoly rights are granted on a district or territory basis, so no other franchise partner is appointed in your allotted area for the Megestrol Acetate portfolio. This is confirmed in writing in your agreement.

It is prescribed by medical oncologists, palliative-care physicians, gynaecological oncologists and physicians managing HIV-associated wasting.

Yes. Oncology and palliative molecules face far less price undercutting than general generics, sustain healthier per-unit margins, and carry strong brand continuity because oncologists rarely switch a stabilised patient. Demand concentrates in cancer hospitals and palliative units, which become durable accounts once supply reliability is proven.

A valid Drug License and a GST registration number are required. Share these along with your preferred territory and our team will confirm availability and send the price list and agreement.